Record overview
Status and phase
Status: RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Condition: Malignant Solid Tumors
NCT06737731
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal
Stopped reason
Context when available
No stop reason available in the current public record.